ToxStrategies Acquires Suttons Creek
Private Equity Professional
AUGUST 14, 2024
ToxStrategies , a portfolio company of Renovus Capital Partners that provides scientific consulting services, has acquired Suttons Creek. Suttons Creek provides pharmaceutical companies with consulting services—conceptualization, device engineering, and quality assurance—for developing drug and medical device combinations.
Let's personalize your content